CPC
AUPH icon

Cookson Peirce & Co’s Aurinia Pharmaceuticals AUPH Stock Holding History

Cookson Peirce & Co’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78M Sell
104,992
-17,491
-14% -$279K 0.06% 151
2026
Q1 		$1.82M Buy
+122,483
New +$1.79M 0.08% 114

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cookson Peirce & Co's AUPH Position: Q2 2026 in Review

Cookson Peirce & Co reduced its Aurinia Pharmaceuticals (AUPH) stake by 14% in Q2 2026, selling an estimated $279K and leaving 104,992 shares worth $1.78M. The position accounts for 0.06% of the portfolio, ranked #151.

Cookson Peirce & Co first reported a position in AUPH in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.82M in Q1 2026. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Cookson Peirce & Co held 104,992 shares of Aurinia Pharmaceuticals worth $1.78M as of Q2 2026.
  • Cookson Peirce & Co sold 17,491 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $279K.
  • Aurinia Pharmaceuticals made up 0.06% of Cookson Peirce & Co's portfolio in Q2 2026, its #151 holding.
  • Cookson Peirce & Co first reported a position in Aurinia Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Cookson Peirce & Co's Aurinia Pharmaceuticals position peaked at $1.82M in Q1 2026.
  • 283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Cookson Peirce & Co's 13F filing for Q2 2026, filed 23 Jul 2026.